Key Considerations
- Key questions solicit design input regarding interoperability, security, and single or dual MTFs, as well as experience communicating with pharmacy switches and 340B covered entity TPAs.
- CMS seeks stakeholder feedback regarding both the immediate functionality needs to implement the MFP for the 10 Part D drugs selected for price applicability year 2026 and the ability to later implement the MFP for Part B drugs and biologicals.
Next Steps for Stakeholders
- Stakeholders must submit responses by 11:00 a.m. ET on November 13, 2023, to Benjamin Stidham at IRARebateandNegotiation@cms.hhs.gov with “MTF RFI” in the response email's subject line, in a format readable in Microsoft Word or Adobe PDF, and containing the information in the format specified in the RFI to be considered by CMS.